Skip to main content

Table 4 Procedure-related complications

From: Long-term outcome after mitral valve replacement using biological versus mechanical valves

  Biological MVR
N = 265
Mechanical MVR
N = 59
Odds Ratio
95% CI
Adjusted Odds Ratioa
95% CI
Wound infection, % 9/265 (3.4) 1/59 (1.7) 2.04 (0.25–16.41) 1.01 (0.11–9.77)
Pericardial tamponade, % 21/265 (7.9) 5/59 (8.5) 0.93 (0.34–2.58) 0.67 (0.22–2.05)
AV block grade III, % 22/265 (8.3) 5/59 (8.5) 0.98 (0.35–2.70) 0.57 (0.18–1.75)
Pneumonia, % 27/265 (10.2) 5/59 (8.5) 1.23 (0.45–3.33) 1.02 (0.35–2.97)
Pneumothorax, % 2/265 (0.8) 2/59 (3.4) 0.22 (0.03–1.57) 0.22 (0.02–1.98)
Pleural effusion, % 12/265 (4.5) 1/59 (1.7) 1.59 (0.19–13.44) 1.62 (0.18–14.45)
Atrial fibrillation, % 59/265 (22.3) 9/59 (15.3) 1.60 (0.74–3.44) 1.09 (0.47–2.51)
MVI ≥ II post OP, % 6/264 (2.3) 1/59 (1.7) 1.35 (0.16–11.42) 1.86 (0.20–17.31)
Immediate 72 h procedural mortality, % 6/265 (2.3) 0/59 (0) n.a. n.a.
  1. Legend: Values are patients applicable/patients with available information with percentage in brackets
  2. AV atrioventricular, MVI mitral valve insufficiency, n.a. not applicable
  3. aOdds Ratios were calculated by logistic regression and adjusted for age, logistic EuroScore -I, CAD and MV insuff. Grade ≥ II (preOP)